Prospective Cohort Study of Patients With Early Alzheimer's Disease Treated With Lecanemab
NCT06741553
·
clinicaltrials.gov ↗
RECRUITING
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Alzheimer Disease
Mild Cognitive Impairment (MCI)
Interventions
DRUG:
Lecanemab 10 mg/kg
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University